ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000547.1|Salivaricin_1 # 3 # 152 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.407	BGC0000547.1|Salivaricin_1 	3	152	+	Loose	740	20.7866	tet(30)	20.51	3000561	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTTATTATTTCGATGAGACTGGGGCTATGGTGGATCAAAGTAAACCTTTGTATCGTGCCGATGCCATTCCAAATAACTCTATCTATGCGGTTTATAACCAGGCCTACGACACGTCAAGCAAGAGTTTTGAACACTTGGACAATTTCTTGA	FIISMRLGLWWIKVNLCIVPMPFQITLSMRFITRPTTRQARVLNTWTIS	MNKALIVILSTVALDAIGAGLIFPILPDILVEVTGGGDIGFLYGVMLGVFAVMQFVFSPILGALSDRFGRRPVLLLSLAGTLLDYLVMAFSPLGWVLVVGRAMAGITSANMAVASAYITDITPAEQRAQRFGTVGAVMSLGFIIGPVIGGVIGAWWLRAPFLVAALFNGLNLFVALFVLPESRKAGPGKFAFKELNPLAPLVWLWNFKPLLPLVTVSVVFGLVAAIPGTIWVLYGAERFGWDSVHMGLSLSVFGVSGALAQAFLVGPLSRRFGDLGTLMIGVGFDMLAYMLMAFANQSWMGYAVAPLFALGGVAMPALQSLVTSRVSDDQQGQLQGVLASLMSLAGIIGPVLTTAVFFSTKSIWIGTIWLVGAALYLLALPLFATVKTPKAVAA	12.44	gnl|BL_ORD_ID|1790|hsp_num:0	1917			438	555	tetracycline
BGC0000547.1|Salivaricin_2 # 335 # 3844 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.457	BGC0000547.1|Salivaricin_2 	335	3844	+	Loose	500	28.8758	NDM-47	28.72	3007447	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NDM beta-lactamase	ATGAGCTATGACTTGGCAGCTGCTGCCGAAACGGTGCAACGAGGAATTGAGGAACGTATTGGTCGCGAGGGCAATACCACTTGGCTTCGCCAGTTGATGTCAGATTTCATCAAAACACAGCCTGGCTGGAACTCTGAGAGTGAGGACAATCTCTTAGTTGGTAAAGACCACTTGCAAGGAGGCGCACTGACTTTCCTCAATAATAGTGCGACAAGTCATGCCAATTCAGACTTCCGCCTCATGAACCGCACACCGACTAACCAAACGGGGACACGCAAATACCATATTGACCGTTCAAATGGTGGTTACGAGTTGCTCTTGGCAAACGATATCGACAACTCTAACCCAGCTGTTCAGGCTGAACAACTAAACTGGCTCCACTACATCATGAATATTGGTTCTATCCTTGGCAATGATCCAAGTGCCAACTTTGACGGTGTTCGTATCGATGCGGTGGACAATGTGGATGCGGACCTCTTGCAAATTGCTTCTGACTACTTCAAGGAAAAATACCGTGTGGCTGACAATGAAGCCAACGCCATTGCTCACTTGTCAATCCTTGAAGCTTGGTCCTACAATGACCACCAATACAACAAGGATACCAAGGGTGCTCAGTTGTCCATTGACAATCCACTACGTGAAACGCTTTTGACAACTTTCTTGCGTAAGAGCAATTACCGTGGCAGCTTGGAGCGCGTGATTACTAACTCTCTTAACAACCGTTCAAGTGAGCAGAAACACACGCCACGTGATGCCAATTATATTTTCGTGCGAGCCCATGATAGTGAAGTGCAAGCTGTTTTGGCCAATATCATCAGCAAGCAGATTAATCCAAAAACAGATGGTTTCACCTTCACTATGGATGAGCTCAAACAGGCTTTTGAAATCTACAATGCGGACATGCGCAAGGCTGATAAAAAGTACACCCAGTACAATATCCCAGCTGCCTATGCCACAATGTTGACCAACAAGGATAGTATCACTCGTGTTTACTACGGAGATCTCTTTACCGACGATGGCCAATACATGGCTGAAAAATCACCATACTATAATGCCATCAATGCCCTGCTTCGTGCTCGCATTAAATATGTAGCAGGTGGTCAAGACATGAAGGTTACTAAGCTTAATGGCTATGAAATCATGTCATCTGTACGTTATGGTAAGGGGGCAGAAGAAGCCAACCAACTTGGTACTGCCGAGACACGCAACCAAGGAATGCTCGTCCTTACAACCAACCGTCCAGATATGAAGTTGGGGGCAAATGACCGTTTGGTGGTCAATATGGGAGCTGCCCACAAAAATCAGGCCTACCGTCCATTGCTTCTCAGCAAATCGACAGGTCTTGCGACCTACCTCAAGGATTCTGATGTGCCAGCTGGATTGGTTCGCTATACGGATAATCAAGGGAACTTGACCTTCACGGCAGACGATATTGCTGGTCATTCAACCGTTGAAGTTTCAGGTTATTTGGCAGTTTGGGTGCCAGTAGGTGCTTCTGAAAACCAAGATGCCCGTACCAAGGCTTCGAAGACTAAGAAGGGTGAGCAGGTCTTTGAATCATCAGCAGCTCTTGACTCACAAGTCATTTACGAAGGCTTCTCAAACTTCCAAGATTTCGTTAAGATACCAAGTCAGTACACCAACCGTGTTATTGCTCAAAATGCCAAACGCTTCAAAGAGTGGGGAATCACTTCCTTTGAATTTGCGCCACAATACGTGTCTAGCCAAGACGGCACTTTCTTGGATTCTATCATTGAAAATGGCTATGCCTTCGAGGACCGTTACGATATTGCCATGAGCAAGAACAACAAATACGGTTCACTCAAAGACCTCATGGATGCTCTTCGTGCCCTTCACGCTGAAGGTATCTCAGCCATTGCTGACTGGGTTCCAGATCAAATTTACAATCTCCCTGGAAAAGAAGTGGTAACAGCTTCACGTACCAACAGCTACGGCACACCACGTCCAAATGCTGAAATCTACAATAGTCTCTATGCAGCTAAAACACGTACCTTTGGAAATGACTTCCAAGGCAAGTACGGAGGTGCCTTCCTTGATGAATTGAAGGCAAAATACCCAGCTATCTTTGAGCGCGTGCAGATTTCAAACGGCCGTAAATTGACTACAAATGAGAAAATCACGCAATGGTCAGCCAAGTATTTCAATGGAAGCAATATCCAAGGTACAGGGGCTCGCTATGTCTTGCAAGATAACGCAACAAACCAATACTTCAACCTGAAAGCAGGTCAAACCTTCCTTCCTAAACAAATGACAGAAATCACAGCAACTGGTTTCCGTAGGGTGGGAGATAAGGTCCAATACCTCTCAACGAGTGGCTACCTTGCCAAGAATACCTTCATTCAAATCGGTGCCAACCAGTGGTATTACTTTGATAAGAACGGTAACATGGTCACAGGTGAACAGGTCATTGATGGCAAGAAATACTTCTTCCTAGACAATGGGCTTCAGCTACGTCATGTTCTTCGCCAAGGCAGTGATGGTCACGTCTATTACTACGATCCTAAAGGGGTTCAGGCCTTTAACGGATTCTACGACTTTGCAGGTCCTCGCCAAGATGTTCGCTATTTTGATGGTAACGGTCAAATGTATCGTGGTCTCCACGACATGTATGGCACAACCTTCTATTTCGATGAAAAGACTGGTATTCAAGCTAAAGACAAGTTCATCCGCTTTGCGGACGGTCGCACACGTTACTTCATTCCAGATACAGGAAATCTCGCAGTTAACCGTTTTGCGCAAAATCCTGAAAACAAGGCTTGGTATTTCCTCGATAGCAACGGTTATGCCGTGACAGGTCTTCAAACGATTAACGGTAAGCAGTATTACTTTGACAATGAAGGACGTCAGGTTAAGGGACACTTTGTCACTATCAATAACCAACGTTACTTCCTTGATGGCGATAGCGGTGAAATTGCTCGTTCACGCTTTGTGACGGAAAACAACAAGTGGTACTATGTCGATGGCAATGGTAAGCTGGTTAAAGGCGCTCAAGTTATCAATGGTAATCACTACTATTTCAACAATGATTATAGCCAAGTCAAGGGTGCCTGGGCTAACGGCCGTTACTATGATGGTGACTCAGGTCAGGCCGTAACCAACCGCTTTGTCCAAGTCGGTGCCAACCAATGGGCTTACCTCAACCAAAATGGTCAAAAGGTAGTCGGTCTCCAGCATATCAATGGTAAACTTTACTACTTTGAAGGCAACGGTGTCCAAGCTAAAGGGAAACTTCTGACTTACAGAGGTAAGAAATACTACTTTGATGCCAATAGTGGTGAAGCCGTAACCAATCGCTTTATCCAAATTTCTCGTGGTGTTTGGTATTACTTTAACGCCTCAGGCCAAGCCGTAACAGGTGAGCAAGTCATCAACGGTCAACACCTCTACTTTGACGCTTCTGGCCGTCAGGTCAAAGGCCGTTACGTCTGGGTTAAAGGCCAACGCCGTTACTATGACGCCAATACTGGAGCTTGGGTCAGAAAACGATAA	MSYDLAAAAETVQRGIEERIGREGNTTWLRQLMSDFIKTQPGWNSESEDNLLVGKDHLQGGALTFLNNSATSHANSDFRLMNRTPTNQTGTRKYHIDRSNGGYELLLANDIDNSNPAVQAEQLNWLHYIMNIGSILGNDPSANFDGVRIDAVDNVDADLLQIASDYFKEKYRVADNEANAIAHLSILEAWSYNDHQYNKDTKGAQLSIDNPLRETLLTTFLRKSNYRGSLERVITNSLNNRSSEQKHTPRDANYIFVRAHDSEVQAVLANIISKQINPKTDGFTFTMDELKQAFEIYNADMRKADKKYTQYNIPAAYATMLTNKDSITRVYYGDLFTDDGQYMAEKSPYYNAINALLRARIKYVAGGQDMKVTKLNGYEIMSSVRYGKGAEEANQLGTAETRNQGMLVLTTNRPDMKLGANDRLVVNMGAAHKNQAYRPLLLSKSTGLATYLKDSDVPAGLVRYTDNQGNLTFTADDIAGHSTVEVSGYLAVWVPVGASENQDARTKASKTKKGEQVFESSAALDSQVIYEGFSNFQDFVKIPSQYTNRVIAQNAKRFKEWGITSFEFAPQYVSSQDGTFLDSIIENGYAFEDRYDIAMSKNNKYGSLKDLMDALRALHAEGISAIADWVPDQIYNLPGKEVVTASRTNSYGTPRPNAEIYNSLYAAKTRTFGNDFQGKYGGAFLDELKAKYPAIFERVQISNGRKLTTNEKITQWSAKYFNGSNIQGTGARYVLQDNATNQYFNLKAGQTFLPKQMTEITATGFRRVGDKVQYLSTSGYLAKNTFIQIGANQWYYFDKNGNMVTGEQVIDGKKYFFLDNGLQLRHVLRQGSDGHVYYYDPKGVQAFNGFYDFAGPRQDVRYFDGNGQMYRGLHDMYGTTFYFDEKTGIQAKDKFIRFADGRTRYFIPDTGNLAVNRFAQNPENKAWYFLDSNGYAVTGLQTINGKQYYFDNEGRQVKGHFVTINNQRYFLDGDSGEIARSRFVTENNKWYYVDGNGKLVKGAQVINGNHYYFNNDYSQVKGAWANGRYYDGDSGQAVTNRFVQVGANQWAYLNQNGQKVVGLQHINGKLYYFEGNGVQAKGKLLTYRGKKYYFDANSGEAVTNRFIQISRGVWYYFNASGQAVTGEQVINGQHLYFDASGRQVKGRYVWVKGQRRYYDANTGAWVRKR	MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQHTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMDALHAAGIATYANALSNQLAPLEGMVAAQHSLTFAANGWVEPATAPNFGPLKVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAFPKASMIVMSHSAPDSRAAITHTARMADKLR	432.96	gnl|BL_ORD_ID|4947|hsp_num:0	5939			366	648	
BGC0000547.1|Salivaricin_3 # 4148 # 4459 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=6bp;gc_cont=0.365	BGC0000547.1|Salivaricin_3 	4148	4459	+	Loose	500	29.261	TEM-213	34.69	3001390	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam; penem	antibiotic inactivation	TEM beta-lactamase	ATGACAAGTAAGAAAGAAGATTTGCTAACGCTTTGGGTAATGTTCTTGATAGGTCTTGTAGCTATTTTCGGTGGTGCGATTTATATGAACCATAAAAAAGAACAAGGTTTGTACAAACATGGTTTCAGGCTTTTGGAAGAACAGATTGGAAGTTATGTTATTGAACATTATTCAGGGGTTGAAAAGGTTGAGTTTTCACCAATTTTTATTAATACTGATGGGATGTTTACCGCAAAAGTTGTGCCTGTAATCTATGATTTGCACGGAAATAAAGCCTACCTTGGTCGACCAGTAAAAGGTGGGAGAGATTGA	MTSKKEDLLTLWVMFLIGLVAIFGGAIYMNHKKEQGLYKHGFRLLEEQIGSYVIEHYSGVEKVEFSPIFINTDGMFTAKVVPVIYDLHGNKAYLGRPVKGGRD	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEFSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	36.01	gnl|BL_ORD_ID|654|hsp_num:0	709			255	396	ampicillin
BGC0000547.1|Salivaricin_4 # 4917 # 5114 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.404	BGC0000547.1|Salivaricin_4 	4917	5114	+	Loose	700	25.7942	adeS	41.67	3000549	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGTAAAGCAAGCTCAGAAATCGCTATTCTTGTAAATAGTGAAAGGGTTCATTGCTATACTATGCCTAATGACATTATCGGATTTTCTCATCTACTGAAGGATCTAAAGACCGTGAGCACCCCCCGAAATTATTTTCGAAGCTACTGGTGTCTACTCTCGACGACTTCAGGCTTTTCTAGAAGAAAACAGCTATGA	MSKASSEIAILVNSERVHCYTMPNDIIGFSHLLKDLKTVSTPRNYFRSYWCLLSTTSGFSRRKQL	MKSKLGISKQLFIALTIVNLSVTLFSIVLGYIIYNYAIEKGWISLSSFQQEDWTSFHFVDWIWLATVIFCGCIISLVIGMRLAKRFIVPINFLVEAAKKISHGDLSARAYDNRIHSAEMSELLYNFNDMAQKLEVSVKNAQVWNAAIAHELRTPITILQGRLQGIIDGVFKPDEVLFKSLLNQVEGLSHLVEDLRTLSLVENQQLRLNYELFDLKAVVEKVLKAFEDRLDQAKLVPELDLTSTPVYCDRRRIEQVLIALIDNAIRYSNAGKLKISSEVVADNWILKIEDEGPGIATEFRDDLFKPFFRLEESRNKEFGGTGLGLAVVHAIIVALKGTIKYSNQGSKSVFTIKISMGHEEMG	18.01	gnl|BL_ORD_ID|166|hsp_num:0	183			534	606	tigecycline; tetracycline
BGC0000547.1|Salivaricin_5 # 5134 # 5685 # 1 # ID=1_5;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.397	BGC0000547.1|Salivaricin_5 	5134	5685	+	Loose	700	27.335	Mef(En2)	28.12	3004659	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGGAAGCTAAGAAGCAACTTGATGGATTACGAGTTCGGAAAACCGATAAGATTGATGCAGAGAAACTAGCTTCGTCACAATTCGTTTTAAGCCGTAAGCCAACTTACGTTCAAGAAGAAGTCTATCAAAACTTGCATGATCTTAGCCGATTCTACCAAAATCTGACAGAGGATATCGTAAGGACGAAGAATAGGCTGCACAAAGTTCTTCAAGTCGCCTTCCCAGAAATCGAGATTCTACTATTTATTCCTACAGGTGAGCAATATTGGAATCTCGTGTCCATCTTCCCAACAAAGCATTGGGTGTTGGAATTATCAGAAGTTGAGTTGAAAGAGACTATTCGCAACTCAACCTCTAAACGCATTTCAGAGAACAGAGTAGGTAACTTGGCTGAGAAGTTAGTTGGACTGGCAAAGCAATCGTATTCTGCCACTTCAAAAACCTCTCCTATGATAGAAGAGGTTAAGTATAATGGCTCTATAATTTCTGTAGTGGGTAAAACCACTGTAGAGATTATAGAGCTTTTTGAGTGTACACAAAAAGTCCCATAA	MEAKKQLDGLRVRKTDKIDAEKLASSQFVLSRKPTYVQEEVYQNLHDLSRFYQNLTEDIVRTKNRLHKVLQVAFPEIEILLFIPTGEQYWNLVSIFPTKHWVLELSEVELKETIRNSTSKRISENRVGNLAEKLVGLAKQSYSATSKTSPMIEEVKYNGSIISVVGKTTVEIIELFECTQKVP	MNHWKSTLAVIGIGQLISILTSTIVGFSIIFWISNEFKSPTALSLAILAGFLPQFVLGLFAGVYVDRWNRKKTMFYSDLFIAFCTLCLFIVITKGYKDLSFFYLLTACRSIGSTFHAPALQASIPLLVPKHHLVRVSGLYHSIQSFSEVIAPVVGASLVVWLPIQYILLIDVIGAVAACLTLLCVQIPSLQKTKVLPDFKKELTEWLHTLRRTMGILPLFVCFTLVTFVLMPVFTLFPFMTLLHFNGNILQMGVVEMGWGSGALLGGLVLACKALKSKQTLVMHTAYVILGLYLISASYLPSSAFIGFVCLTFTGGIAYSIYHALFIAIIQQNLASDMLGRTFSLIFSLSTFPSMLGIVASGYWVEAWGITSVFMISGWVIFLIGVGANFISSIKQLDNYA	45.64	gnl|BL_ORD_ID|2200|hsp_num:0	3359			882	1158	
BGC0000547.1|Salivaricin_6 # 5729 # 6547 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.396	BGC0000547.1|Salivaricin_6 	5729	6547	+	Loose	782	26.1794	CMY-150	34.48	3005016	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGAGACTTATTAAGAATACCACAGAATTAATCGGAATTAAAGACCAAAACATCAAGATTTCACTTGTTTTTGAAACTAACACTCATTTAGAGATTCAAGCAAAACTTGATTATCCTGCACCATCATGTCCTCATTGCCATGGAAAAATGATCAAGTACGACTTTCAAAAGCCTTCTAAAATCCCTCTTCTCGAGCAAGCGGGAACTCCAACTCTACTACGTCTGAAGAAGCGTCGTTTCCAGTGTAAAAATTGTAGGAGAGTCACGGTAGCTGAGACATCAATCGTTGAGAAAAACTGCCAAATCTCCAATCTAGTCCGACAAAAGGTTGCACAACTCTTGACTCAGAAGATGTCATTAACGGATATTGCCAGAAGACTTCGTGTGTCGACATCCACTGTCTATCGTAAGCTCGACCAGTTTACTTTCAAGGAACATTATGACAAACTTCCAGCTGTTATGTCCTGGGATGAGTTTGGATTCAAGAAAGGGGAATTGGCTTTTGTAGCGCAGAATTATGAGACCAACCAACTCATAACCATCCTTGATAATCGCCGCCAAACCACTATACGAAACTACTTTTTAAAGTATCCATTAAAAGCTCGCCAAAAGGTACAGTTTATCACGATGGATATGTCCGGAGCTTATATTCCACTTGCCAAAAGACTTTTTCCAAACGCTAAAATCGTTCTTGATCGTTTCCACATTATCCAGCACCTTGGTCGTGCCTTTTTAAAGACAAGAATTATGATTATGAACCAATTCGATAAGAAGTCACTACCCTATCGAGCCTTGAAAAATCATTGGCGACTCTTCTAA	MRLIKNTTELIGIKDQNIKISLVFETNTHLEIQAKLDYPAPSCPHCHGKMIKYDFQKPSKIPLLEQAGTPTLLRLKKRRFQCKNCRRVTVAETSIVEKNCQISNLVRQKVAQLLTQKMSLTDIARRLRVSTSTVYRKLDQFTFKEHYDKLPAVMSWDEFGFKKGELAFVAQNYETNQLITILDNRRQTTIRNYFLKYPLKARQKVQFITMDMSGAYIPLAKRLFPNAKIVLDRFHIIQHLGRAFLKTRIMIMNQFDKKSLPYRALKNHWRLF	MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLATYTAGGLPLQIPDDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGALVVKHSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASLVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPARVEAAWRILEKLQ	71.39	gnl|BL_ORD_ID|2749|hsp_num:0	3760			483	570	
BGC0000547.1|Salivaricin_7 # 7045 # 7248 # 1 # ID=1_7;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.402	BGC0000547.1|Salivaricin_7 	7045	7248	+	Loose	2130	25.7942	mtrD	34.48	3000811	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGACAAACCGTCGGGAACAAGTTTTAGAACAGTTGGTAGAGTTAGCTAAACCTCTACCTGAATATGAGATTCTTCTCTCTATTCCTGGTATCGCAGAAACAACGGCTACAAGCGTTATTGGCGAATTAGGAGACATTCGTCGCTTTAAGTCTGCTAATCAAATCAACGCTTTTATCGGTATTGATCTCAACCACTATGAATAG	MTNRREQVLEQLVELAKPLPEYEILLSIPGIAETTATSVIGELGDIRRFKSANQINAFIGIDLNHYE	MAKFFIDRPIFAWVISIFIIAAGIFGIKSLPVSQYPSVAAPTITLRATYPGASAQVMEDSVLSVIERNMNGVEGLDYMSTSADSSGSGSVSLTFTPDTDENLAQVEVQNKLSEVLSTLPATVQQYGVTVSKARSNFLMIVMLSSDVQSTEEMNDYAQRNIVPELQRIEGVGQVRLFGAQRAMRIWVDPKKLQNYNLSFADVGSALSAQNVQISAGSIGSLPAVRGQTVTATVTAQGQLGTAEEFGNVILRANTDGSNVYLKDVARVGLGMEDYSSSTRLNGVNTTGMAVMLSNSGNAMATAKAVKERMATLEKYFPQGMSWKTPYDTSKFVEISIEKVIHTLIEAMVLVFVVMYLFLQNIRYTLIPTIVVPISLLGGFAFISYMGMSINVLTMFAMVLVIGIVVDDAIVVVENVERIMAGEGLPPKEATKKAMGQISGAVIGITAVLISVFVPLAMFSGATGNIYKQFALTMASSIAFSAFLALTLTPALCATMLKTIPKGHHEEKKGFFGWFNKKFNSWTHGYEGRVAKVLRKTFRMMVVYIGLAVVGVFLFMRLPTSFLPTEDQGFVMVSVQLPAGATQERTNATLAQVTQLAKSIPEIENIITVSGFSFSGSGQNMAMGFAILKDWNERTAPGSDAVAIAGKLTGMMMGTLKDGFGIAVVPPPILELGNGSGLSINLQDRNNTGHTALLAKRNELIQKMRASGLFDPSTVRAGGLEDSPQLKIDINRAAAAAQGISFADIRTALASALSSSYVSDFPNQGRLQRVMVQADEDARMQPADILNLTVPNKSGVAVPLSTIATVSWENGTEQSVRFNGYPSMKLSASPATGVSTGQAMAAVQKMVDELGGGYSLEWGGQSREEAKGGSQTLILYGLAVAAVFLVLAALYESWSIPLAVILVIPLGLIGAAAGVTGRNLFEGLLGSVPSFANDIYFQVGFVTVMGLSAKNAILIIEFAKDLQAQGKSAVEAALEAARLRFRPIIMTSFAFILGVVPLYIAGGASSASQRAIGTTVFWGMLIGTLLSVFLVPLFYVVVRKFFKETAHEHEMAVKHAAEAGITGSDDSQH	6.28	gnl|BL_ORD_ID|1786|hsp_num:0	1938			1746	1833	erythromycin; penicillin; azithromycin
BGC0000547.1|Salivaricin_9 # 7726 # 9093 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=8bp;gc_cont=0.292	BGC0000547.1|Salivaricin_9 	7726	9093	-	Loose	910	78.1814	smeS	21.98	3003067	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTTAAACTACGTGTAGTAACACAATTTATTAGACGTTTTATTGTTTCAGTCATAGTAATGTCCATAATAAACATTTTTATTATAGTTTTTTTTGTTTTTAGCCAAGCAAATCAAACTAATGTGATGGATACAGTGAGTAGCCTAGTCAAACAACTTGATATCAGTTCTAATTCTGCCAAATTATCTAACTTGGGTAAAAAATTAGCTAATTCTAAAGAGGTATGGATTATGGTTTTAGACTCTGATAGTGGAAAGGAAATTTATGAATATAAAAAGCCAAGTGAAGTCCCAACACAGTATAGTCTAACTGACGTCGCTAAGTTTACACGTTATTATTTAAATGATTACCCTGTATTCGTACAAATTATTAACAATAAGATTCTTGTTTTTGGATTTTCAAAAGATAATGTGTTTAAATTTCCTTTCAATTATTATGAAAAATCCGACCTTCACAACCTCTTTATTTTAGCTTTTTTTCTACTTGGAATAAATTGCCTGTATCTATTAATCATTTATACCTATAGTACTAGAGTAGTCCAACGTAAAATTACCCCTTTAGTTTCAGCAATTCAAAAACTACCAGAAGGCCTAAGTGGCTCTGTTGCAACTCAAGATGAGCTAAAACAATTAACGGAGGCTATAAATATTGCTGACAATAAACTTAAAGAAGGGGAGCTTTTTAAAGAAAATTGGATTTCTGGTATAGCACATGATATAAAGACACCTCTGTCCGTTATTATTTCAAATGCTTCTCTTATTAAGTCTGATACAGCAGATAAAAATCAATTAAGACGTTTACGATCCATCCTTAATGAGAGCTATTATATTCAAAACACTATAAATGACTTAAATATTTTTGCCAGATTAACTAATAACCAGTTTAGTCTAAAACTAGAATCAGTCAAAATAATTTCTTTCTTCAGGAAAATCATTATACAAATAATAAATCAAGAAGTCTGGGAAAATTCAAATTTTGCATTTGAATTTGATGATAAACTTCAAAATAGTACAATTTCAATTGAGAAAAACTTAATTTCACGCGTACTTCATAATATTATATATAACTCAATTCTCCATAATCCCGAAGGCTGCAATGTGAATATTCGTCTACACAGAGATAAAGAATTTTTAATAATTACAATTGAGGATAATGGCATAGGCATAACAAATGATAAGCTATTATCAATTCATAATAGTAATAAAATCATTGAAGAATTTGACATCTCAGGAATTAGACGACACGGTATGGGATTAAAAATCTCAAAACAAATTATCGAAGTTCATGAGGGAAGCTTTAAAGTGGAAAGTAAAGAGAAACAATTCTTTAGAGTTATAATTACTTTACCTTTAGAAGGTGAAGTATAA	MFKLRVVTQFIRRFIVSVIVMSIINIFIIVFFVFSQANQTNVMDTVSSLVKQLDISSNSAKLSNLGKKLANSKEVWIMVLDSDSGKEIYEYKKPSEVPTQYSLTDVAKFTRYYLNDYPVFVQIINNKILVFGFSKDNVFKFPFNYYEKSDLHNLFILAFFLLGINCLYLLIIYTYSTRVVQRKITPLVSAIQKLPEGLSGSVATQDELKQLTEAINIADNKLKEGELFKENWISGIAHDIKTPLSVIISNASLIKSDTADKNQLRRLRSILNESYYIQNTINDLNIFARLTNNQFSLKLESVKIISFFRKIIIQIINQEVWENSNFAFEFDDKLQNSTISIEKNLISRVLHNIIYNSILHNPEGCNVNIRLHRDKEFLIITIEDNGIGITNDKLLSIHNSNKIIEEFDISGIRRHGMGLKISKQIIEVHEGSFKVESKEKQFFRVIITLPLEGEV	MAFAMAKFQLKFGLTAKTFLAIFTACLLVLAVNGIASRVAFQTGFLDYLNDQGDLRMQRLMPHLQREYREHGGWEHLHGDGDRWARLLRPDLAHGHEGPVPSLSDQTGVPSRLGLFDAQHRFVAGNPDATSDDEPHAVQVDGQTVGWLGMVPFQTVIATNDLNFYNTQVRAWWVIGIALLLVTVLLAWLVSRALRQRLAKLAAATHRLAAGDYATRIERTSDDELDALVNDFNRMAQALDDTERNRRAFIADISHELRTPLAVVRAELEAIEDGIRPLDRANLVGLQGEIRQLGKLIDDLHDLSMTQSGGLAYRFAPLDLVALLRSELNGMRVRFANAGLALEEDLPATPLQVSGDERRLQQVLANLLENALRYTHAGGRVRVQAARVPAGVQLVVEDTAPGVPPDKCALVFERFYRVESSRNRASGGSGLGLAISHNIILAHHGVIHAAPSPLGGLRVVITLPEPA	97.43	gnl|BL_ORD_ID|312|hsp_num:0	342			222	1392	
BGC0000547.1|Salivaricin_10 # 9105 # 9803 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGAGA;rbs_spacer=4bp;gc_cont=0.309	BGC0000547.1|Salivaricin_10 	9105	9803	-	Loose	400	147.517	vanR gene in vanI cluster	36.36	3003728	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGGATATCGAAGCGCCTTTTTTGGCTAGGAAAATATTGGTTGTTGATGATGATGTTGCGTTAAATCATTCAATAAGGGAGATACTGTCAGTTTCTGGTTTCTCAAAAATATATAGTGCATACAGCATCAGTGAAGGAATAGAGTCTTTTGTTAAAAATTCTATTGATTTGATTATATTAGATGTCATGCTTCCTGACGGGGAAGGGTATTTATTATCAAAATATGTTAGAAAAGAATCTGATATTCCAATTCTTTTTCTAACAGCAAAAAATGAACCTGAAGATGAAATTCAAGGTCTACAATCTGGAGGAGATGATTTTATAACTAAGCCTTTCCTACCTAAAATTCTCATTTATCGTACGATTTCGCTTCTTCGGCGATCGTACAAAGAAGACAGTAATACTATTAAATTAGATCATTGTATTATTAATTTAGGGAATGCAATTGTTGAAAAAGATAATGAAAAATTATCTTTAACCCCAATAGAAATTCAAATCATTCGAAAATTGTATGATAATAAAAACTATATTGTATCTACAGAAGCGATTTGTGATACAGTATGGGGTATTGATAGCTTTGGATATGAAAAATCTTTAATGGTTCATATTAGAAATATCAGAGAAAAAATCGAACTTAATCCTTCAAAGCCACAATACTTGGTTACTGTTAAAGGACTTGGCTACAAACTAATGGTGTAG	MDIEAPFLARKILVVDDDVALNHSIREILSVSGFSKIYSAYSISEGIESFVKNSIDLIILDVMLPDGEGYLLSKYVRKESDIPILFLTAKNEPEDEIQGLQSGGDDFITKPFLPKILIYRTISLLRRSYKEDSNTIKLDHCIINLGNAIVEKDNEKLSLTPIEIQIIRKLYDNKNYIVSTEAICDTVWGIDSFGYEKSLMVHIRNIREKIELNPSKPQYLVTVKGLGYKLMV	MAANILIVDDEQAIADLVEVYLKNENYNLFKFYNGKDALDCIEKEKLDLAILDVMLPDVDGFSICRQIREKHNFPVIMLTAKEEEIDKITGLTLGADDYITKPFRPLELIARVKAQLRRFTKYNSAEPNQEEHVIAFSGLVLDMDTHECTLNEKKLSLTPTEFSILWVLCSNRGRVVSSEELFSEVWGDKYFTNSNNTVMVHIRHLREKMQDSAEHPKYIKTVWGVGYKIEK	100.00	gnl|BL_ORD_ID|2065|hsp_num:0	2246			0	690	vancomycin; teicoplanin
BGC0000547.1|Salivaricin_11 # 10001 # 10171 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=8bp;gc_cont=0.351	BGC0000547.1|Salivaricin_11 	10001	10171	+	Loose	1050	25.0238	srmB	39.29	3002828	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGAAATCAACAAATAATCAAAGTATCTCAGAAATTGCAGCAGTAAACTCACTACAAGAAGTAAGTATGGAGGAACTAGACCAAATTATTGGTGCCGGAAACGGAGTGGTTCTTACTCTTACTCATGAATGTAACCTAGCAACTTGGACAAAAAAACTAAAATGTTGCTAA	MKSTNNQSISEIAAVNSLQEVSMEELDQIIGAGNGVVLTLTHECNLATWTKKLKCC	MSIAQYALHDITKRYHDCVVLDRVGFSIKPGEKVGVIGDNGSGKSTLLKILAGRVEPDNGALTVVAPGGVGYLAQTLELPLDATVQDAVDLALSDLRELEAAMREAEAELGESDENGSERELSAGLQRYAALVEQYQARGGYEADVRVEVALHGLGLPSLDRDRKLGTLSGGERSRLALAATLASSPELLLLDEPTNDLDDRAMEWLEDHLAGHRGTVIAVTHDRVFLDRLTTTILEVDSGSVTRYGNGYEGYLTAKAVERERRLREYEEWRAELDRNRGLITSNVARMDGIPRKMSLSVFGHGAYRRRGRDHGAMVRIRNAKQRVAQLTENPVHAPADPLSFAARIDTAGPEAEEAVAELTDVRVAGRLAVDSLTIRPGERLLVTGPNGAGKSTLLRVLSGELEPDGGSVRVGCRVGHLRQDETPWAPGLTVLRAFAQGREGYLEDHAEKLLSLGLFSPSDLRRRVKDLSYGQRRRIEIARLVSDPMDLLLLDEPTNHLTPVLVEELEQALADYRGAVVVVTHDRRMRSRFTGARLTMGDGRIAEFSAG	10.18	gnl|BL_ORD_ID|110|hsp_num:0	128			1491	1575	spiramycin
BGC0000547.1|Salivaricin_12 # 10339 # 13122 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.298	BGC0000547.1|Salivaricin_12 	10339	13122	+	Loose	500	27.335	APH(6)-Ia	38.71	3002657	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	ATGAAGTATAACCAACTATATGAACAATTTGATAAGTTTCCTTTATTTATAATTAAACAGAAATTTAATTACAAATCATTGGAGAATTCAAATAATAGAAAAGTACTAGAAAAAATTATATTAGATTACTATAGGCCAACATTGATTTACTTAATTAATGAAAAAAGGGTCAATGGCGAGCTAAAAGGTAACACTCCTGAGGAACGCTATGATTATTTTAATCAAGAACTATGTGGTAGTGGTAAAATTTTTGGAGAAATTGAAATAAGATTTCCAGAAATTAATGATAGAATCGAATTAATAGTGAAAAAATACTTAGACTTGCACGAGCGAGTGAAATCTACTTTTGTAAAAGACTTTCGGTTTTTGTGTGATAATAAATTTTTACATTCTGATAAATTGAAACCTGATTTGGATAAGCTTGAAATTGAAGTTACGGGTGATATACATGACGGAGCGGGAGTGTGTATTATCAGTTATAATAATCAAAAGGTAGTATATAAAAGAAAAAGTTCTATAGCAAATAGATTTCTTCGAAAGATAGATTTAATGGTAAGTGAATTTTTTAACGAAGAGATTCGTTTTATTCCAAACATTTTAGATAGAGATGGATATTTTTGGGAACAATATATAAATAATCAAAAATTGAAAAATGCTAATGAGGCCAGGGAATACTACACGAATATGGGTTTCCTATTGTTTTATGCGTATATTTTTAATATTTCAGATTTACATTTTGAAAATATTCTTTCTTCTGGGAAATCGCCAATTTTAGTTGACGTAGAAACTCTCTTTAGTACATCACCATTTGAAATAATAGCTGATAACTTTGCAACCAAGGAGATTACTCAAAGAAGCCGATCCTCGGTACTTTCATCAGGATTACTTCCTATTTCTGAAGCAGAAAAAATATTTGGAGGAGATTTAAGTGGGATCCTTGGTGGAACACTAGTTAATGAATTTAAAACAGTCATTAATAACTACAGAGATGATATTAGAATTGAAAAAGTTGTTCAGGCAACAAAATATCAATCTCATCTGCCATTCTTTGAATATCTTGGTCAGAAGGAATATTTAGTAGCTACTAATTATGTAAATGACATAATAGCTGGTTTTAAGTTAGTGAGTGATTTTTTTCTTAATCATAAGGAAGAAATTCTGGAAGTGTATCAGCAATATTCAGATTTAAAAACACGAATATTGTTTAGAAATACTCATGAATATGACGTAGTTAGTCAGTTGCTTATTTCTCCAATATATTCCCAAAAACAAGATTTACTTTTTAAAAAAATGTCAGAGAAGCTAAGTCACTATGATAGTAGTAAATTGTGTGAATCAGAAGTTAGACAATTACTCAGTATGGATATACCATCTTTCTATATTGAAGCTAATTCTACAATAGTTACCGATGGATATTCGGATGTTTGGAAAATAAGGAAAACTCCCTTGTATTCTGTTACAGAGAAACTTAACAAACTAACTGAAGATAAGATATCTGAACAAGTTGAATTAATAAGATTTTCACTTCAAGCTGATCGTGATTCTGAGAGTACAGAAATGCAGGAACTGTATAAAAAATATGATGATTTTAGAAATGAAGAGAATATCATGATTAATGCTTTGAATAACCTTGTAGATGAGATACTTGCAAAAATGTACCTAGACCCAGATGATGAAAGTATTAATTGGATGACTTTAAAAGTTAATGATCATAACAATTTTGAATTGGTTCCAATGGATAATTCAATTTATGATGGTATCTCGGGGGTAGCATTAAGTTTAATAGAATGTTATTCTTTGTTAGATAAAAATAGAAAAAGAAAAGTTTATAGATGTTTGTGTTATTTGTTTAAAACACTTGTAAATGTGTATTCTAATATTTTAGATATGACCTACTATGTTGGAAGATTAGGGATACTATCAACCTTAGTAAGAATATCTCAAATTACCAAACAAGAAATACCACAAAAAATATTAAATAGTAAAGTTTCTTTGATTAATCAGGCTTTGCAAAATACACCAGCGGATTTTTTAACTGGATTTTCGAGTTCAATACTAGCTTGTGAAGAGGACGAATACTCAGAAGAGTTTCTTCGAACTATGATAAATCGCTTCAAAGAACTTAAACAATATGACAGCAATCATAACTACATTTATTGGGGAAAAGAAGAAAGTAATAATGTTAGCTTAGCACATGGAAATGCAGGTATCGAAATATCATTATTATATTTAGCCGGAAAACTCAAGAGTAGAGATGCTAAGGAAATGTATGAGGATGCTAAAAAATTTGATGATAAGCAGAGATTAGACCAAGGCTGGATAGATAAGAGGTTTTCGGATTCAAATGCTCAATGGTGTCATGGGTCAACAGGAGTATTAATATCTAGGTTAGCTCAGTTAAAGTTAAATCAGGAATTTAAAATTTTAAGTATACAAGAAGAATCCTTGCTTGTAGAAGATATTCAGCATGCAATAAAGCAAATTATCTTAATAGGATTTGATATGAATAATTTTACTTTATGTCACGGAGTCGGTGGAAACCTTTTAGCATTAACTTACTATAATAATTTGTATGGGGGTGAAAATAGCTCGGAATTAGAAGAAATCATTAATTCGGAGTATAGAAAAATGCTTTCATTTGGAATTAAATATGGTTGGATGTGCAGTCTTAATACCAACTTCGATTCTTATGGTTTAATGACAGGACTTGCAGGAATAATTTACTCAGTATCAAAATATTTGAAAAGTGATTCTTCGCTTGAAATTTTAACTCCGGTCTTTTGA	MKYNQLYEQFDKFPLFIIKQKFNYKSLENSNNRKVLEKIILDYYRPTLIYLINEKRVNGELKGNTPEERYDYFNQELCGSGKIFGEIEIRFPEINDRIELIVKKYLDLHERVKSTFVKDFRFLCDNKFLHSDKLKPDLDKLEIEVTGDIHDGAGVCIISYNNQKVVYKRKSSIANRFLRKIDLMVSEFFNEEIRFIPNILDRDGYFWEQYINNQKLKNANEAREYYTNMGFLLFYAYIFNISDLHFENILSSGKSPILVDVETLFSTSPFEIIADNFATKEITQRSRSSVLSSGLLPISEAEKIFGGDLSGILGGTLVNEFKTVINNYRDDIRIEKVVQATKYQSHLPFFEYLGQKEYLVATNYVNDIIAGFKLVSDFFLNHKEEILEVYQQYSDLKTRILFRNTHEYDVVSQLLISPIYSQKQDLLFKKMSEKLSHYDSSKLCESEVRQLLSMDIPSFYIEANSTIVTDGYSDVWKIRKTPLYSVTEKLNKLTEDKISEQVELIRFSLQADRDSESTEMQELYKKYDDFRNEENIMINALNNLVDEILAKMYLDPDDESINWMTLKVNDHNNFELVPMDNSIYDGISGVALSLIECYSLLDKNRKRKVYRCLCYLFKTLVNVYSNILDMTYYVGRLGILSTLVRISQITKQEIPQKILNSKVSLINQALQNTPADFLTGFSSSILACEEDEYSEEFLRTMINRFKELKQYDSNHNYIYWGKEESNNVSLAHGNAGIEISLLYLAGKLKSRDAKEMYEDAKKFDDKQRLDQGWIDKRFSDSNAQWCHGSTGVLISRLAQLKLNQEFKILSIQEESLLVEDIQHAIKQIILIGFDMNNFTLCHGVGGNLLALTYYNNLYGGENSSELEEIINSEYRKMLSFGIKYGWMCSLNTNFDSYGLMTGLAGIIYSVSKYLKSDSSLEILTPVF	MSSSDHIHVPDGLAESYSRSGGEEGRAWIAGLPALVARCVDRWELKRDGGVRSGEASLVVPVLRADGTRAALKLQMPREETTAALIGLRAWGGDGMVRLLDHDEESSTMLLERLDGSRTLASVEDDDEAMGVLAGLLNRLHSVPAPPGLRGLGEIAGAMVEEVPSAVDSLADPEDRSRLRGWASAVAELVGEPGDRVLHWDLHYENVLAAEREPWLAIDPEPLVGDPGFDLWPALDTGWERIEATGDARRVVRRRFDLLTESLELDRGRAAGWTLARLLQNTLWDIEDGLTAIAPSQIAVAEALAKP	301.95	gnl|BL_ORD_ID|1382|hsp_num:0	1500			600	693	streptomycin
BGC0000547.1|Salivaricin_13 # 13139 # 15217 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=7bp;gc_cont=0.275	BGC0000547.1|Salivaricin_13 	13139	15217	+	Loose	1190	105.531	novA	21.5	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAAAGTAATTCTACAAAATAATGAAGAGGACTGTTTACTAGCTTGTTACACAATGCTATTGAATGATTTAGGCTATAAAGTACCTTTGTACGAGGTTTATGAAAGAGATTCACTTCCAGCTGATGGCTTGAGTGTTTCCTATTTACTGACTCTGAATAAAAACTTTAATGTAGATATTAAGGCATATAAGGCTAACTTTGATGAAGTTATTAGTCTAATACGTGTTAGAGGTAATAATAGGGTGATTGTTCATTGGAATAATGATCATTTTGTTGTTCTAGAAAAAATAACCAAAAATTATATAAAAATTGTGGATCCTGCAATAGGAAGAATTAAATTTAGTAAGGATGAATTTTTAGAACACTATTCTGGAACGGTTATTACCGTATTACCGACCGTTGATTTTCATCGTCAAAAAGTGAGGACGCTATTTTTTAAATATTTTAAAAACACACTGGAAGTAAGAGCAATTTTCTCTTTTTTGATTTCGTTACTTTTGATTGAAATTAGTGTTTTGCTATTTTCAATTGTGATAAGAAATATGGTGGCTGGAAATTTAAAATTTATTGCAAGTCTTCTCTTATTGTTTACTATTATATTACTACAAATTGTTGGATATTATATTAAGAATTTTGCGCTAGAAAAATATAATAGTAATTTTGATAAATCTTACACAACTATCTTATTTAAGAGATTGCTCAATAAACCATTACTATATTTTAGAAATCATACCAATGGAAGTATTTCTGAAAAAATAAGTTTCAGAACGACATTGAGAGATAGTGTTGCAACTAAACTAATCCCTTCAATAGTAAGTCTAGTTTCATCATTCGTAATTTTTATATATTTGGTCATAATCTCTTTTAGACTAACTATAATATTAGTTTCTATGATTGTATTATATTCTTTAATATCATCTGTTTTATATTATAAGCAGAACGAATATAATCAATCTTATCTACAATATCTAATTGATTTTAACTCAGATTTTCAATCTGATCTAGAAGATATAGATTACATTAAAGTAATGAGAAACGAGAGGGAAACGGAAGATAGATGGACAAAAAATAATGATCGTTTGACAAGCAAATATTCCCAAATTTTAAAAGTTGAAAATTTTGTTCAACTTTTTGGAAGTATATTTAGCTATTTTAGTTTATCAATTGTTATATTAGCAGTAATTTATAATAATAAATTTTTTAATGTTTCAATAGCAGATTTAGTATTATATCAAACAAGTATTTCATTATTGATTTCATCTATTGAACAAGTGAAAACCTCAATTTTTGAAATAGCACGATTAGCTATATATGCTGAAAAGCAGGGGGATATACTAAAAGAAAATTTACCAATAAATGTTAATTTTGACTTAGATTCAAACTATATAATTCAGACAGAAAATTTAAACTTTGGTTATGGAAATGAATCACTGTATAAACCAGTTAATTTGAAAATTAATCAAGGTGAAAAGATAGCAATTATAGGTAAATCAGGTAGTGGTAAATCTACATTGTTATTATTATTGACTGGCATGTTGAGACATTCTGGCAAGATTACATATAATAGTGAACATCTAGAAAACTATATGGGAGTAATCTTGCAAAATATGACATTGAAAAAAGGAAGTGTATTAGAAAACTTTGAATATGACTCTCCTGATTTAACTAAGCTATCAAAAATACTTGTTGATACCACAGCCGATGAGGTCATTGCTAAACTTCCCAATAAATTGCAATCGAAGTTGTTAAAACAGGGAAAGAATCTTTCGGGAGGACAAATCCAGAAATTATTAATTGCCAAATCATTGTTGAAAGGTGAAAAAATGATTTTTTGGGATGAAGCTTTTAGTAATTTGGATGAAATGAGTAAAGATAAGATTTATGAAAATGTTTTATTGGGAAGTTTCTATAAGGATAAAACGATGTTAATTGTAAGTCACCACTTGGATATTGTGAACTACGTTGATAGTGTTATCTTTATAAATGATGAAACAGGAGAAGTCATCAAATCAACTCACGAAGATTTACAAAAGAACAACTTGGATTACAAGAGATTTATTTGTAATAAAGGTGTCTAA	MKVILQNNEEDCLLACYTMLLNDLGYKVPLYEVYERDSLPADGLSVSYLLTLNKNFNVDIKAYKANFDEVISLIRVRGNNRVIVHWNNDHFVVLEKITKNYIKIVDPAIGRIKFSKDEFLEHYSGTVITVLPTVDFHRQKVRTLFFKYFKNTLEVRAIFSFLISLLLIEISVLLFSIVIRNMVAGNLKFIASLLLLFTIILLQIVGYYIKNFALEKYNSNFDKSYTTILFKRLLNKPLLYFRNHTNGSISEKISFRTTLRDSVATKLIPSIVSLVSSFVIFIYLVIISFRLTIILVSMIVLYSLISSVLYYKQNEYNQSYLQYLIDFNSDFQSDLEDIDYIKVMRNERETEDRWTKNNDRLTSKYSQILKVENFVQLFGSIFSYFSLSIVILAVIYNNKFFNVSIADLVLYQTSISLLISSIEQVKTSIFEIARLAIYAEKQGDILKENLPINVNFDLDSNYIIQTENLNFGYGNESLYKPVNLKINQGEKIAIIGKSGSGKSTLLLLLTGMLRHSGKITYNSEHLENYMGVILQNMTLKKGSVLENFEYDSPDLTKLSKILVDTTADEVIAKLPNKLQSKLLKQGKNLSGGQIQKLLIAKSLLKGEKMIFWDEAFSNLDEMSKDKIYENVLLGSFYKDKTMLIVSHHLDIVNYVDSVIFINDETGEVIKSTHEDLQKNNLDYKRFICNKGV	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	112.52	gnl|BL_ORD_ID|1112|hsp_num:0	1210			72	1794	novobiocin
BGC0000547.1|Salivaricin_14 # 15272 # 16180 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.290	BGC0000547.1|Salivaricin_14 	15272	16180	+	Loose	570	221.861	bcrA	43.05	3002987	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGACAGAAGTAATAAAACTAAAAAAATTGAAGAAAAATTTTAAAGGAGTATCGTCAGTCGATTTAGAAGGACTTACAGTTAGAAAAGGTGAAATTTATGGTTTCCTTGGTCCTAATGGAGCAGGTAAAACCACGACAATGAAGATGATTCTATCATTAATTGAACCTACTTCTGGTTCAATTGAAATAATGAATACTCCAATTAACAGATCGAACGATTATTTAAAATATATAGGTTCAATGATTGAAGAACCTTCTTACTATCCGAATTTAACAGGTTACGAAAATCTATTAGTTTTTCAAAAAATGTTAGGTTTTAAAGAAGAGAATATTTTAAAAACACTTGAACTTGTGGGGCTATCAGAAGAAAAAAATAGAAAAAAATTAGTAAAAGCGTATTCTTTAGGTATGAAACAGCGGTTAGCTCTAGCATTTGCTTTAGTAAAAGAACCTCAGATATTATTATTAGATGAACCTACAAATGGATTAGATCCCTCAGGTATTCATGAGATACGTGAATTGATTATTCGTTTGGCTAAAGATAAGGGATTAACAGTTTTCATTTCTAGTCATATTCTATCTGAAATAGAGCAGATTGCTGACAGGGTTGGAATTATAAATCATGGGAGATTAGTATACGAGGGAGAAATTGAAAAAATAAATACTAATAATTGGGTAGAAATTGAAGGAAAATTTGACATTGAAAAATTAAAAAATCTTTTTGGTAATCATTTTAGTAATAGAAAAGTGGAATATGATGCAAAACTTGTTAAAATCTGGAATACTAATAATGAGCAGATCGCTAATATAGTCCGTTCCTTGTTTGAATTAGACTTTCCAATTTTTCGTGTAGAACATAAAAAAGAAAATCTCGAAGATATATTTTTAGAATTAACTAAGGAGTTATAA	MTEVIKLKKLKKNFKGVSSVDLEGLTVRKGEIYGFLGPNGAGKTTTMKMILSLIEPTSGSIEIMNTPINRSNDYLKYIGSMIEEPSYYPNLTGYENLLVFQKMLGFKEENILKTLELVGLSEEKNRKKLVKAYSLGMKQRLALAFALVKEPQILLLDEPTNGLDPSGIHEIRELIIRLAKDKGLTVFISSHILSEIEQIADRVGIINHGRLVYEGEIEKINTNNWVEIEGKFDIEKLKNLFGNHFSNRKVEYDAKLVKIWNTNNEQIANIVRSLFELDFPIFRVEHKKENLEDIFLELTKEL	MSTIIKTTDLTKMYGSQKSVDHLNINVKQGDIYGFLGRNGAGKTTTIRMLLGLIKPTSGQIEIFGENFFKNKKEILRRIGSIVEVPGFYANLTARENLLINAKIIGIHKKNAIDEVLEIVGLQHETKKLVGKFSLGMKQRLGIARALLHYPELLILDEPTNGLDPIGIKEMRRLIHSLAKERNITIFISSHILSEIEQLVDHVGIIHEGKLLEEIPFDHLKKRNRKYLEFQLSDQNKAVVLMEQHFDIHDYEVHQDGIIRVYSHLGQQGKLNKLFVENGIDVLKITMSEDSLEDYFVKLIGGGTIG	98.69	gnl|BL_ORD_ID|315|hsp_num:0	345			0	897	bacitracin; bacitracin A; bacitracin B; bacitracin F
BGC0000547.1|Salivaricin_19 # 19652 # 20983 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.412	BGC0000547.1|Salivaricin_19 	19652	20983	+	Loose	500	26.1794	CPS-1	28.95	3003716	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CPS beta-lactamase	GTGACTATCGTTTCGAACTCTAATAAACTGTTTCCAAACGTGACAGTAGGTCAATCAAACGGTTCAAATACTAATGTCACTATCATTTCACAAGGAAATCAACAAAATAACTCAGGTTACCAAATCATCACAGGTGAGACTAAACCAAGTGTTGATTCGAACAATGCCAAGTCTTCATTTGTCCGTGTAGGCGAAAATCAATGGTATTATTACGACCAATATGGCCAAAAGGTCAAAGGTGAAAAGGTTATCGATGGTAAGGCTTATTACTTCCTTGAAAATGGTCTTCAAGCTCGTGACTCACTTGTTAAAGGTAGCGATGGCTACACTTATTACTATGATAAAAATGGCGTGAAAGCTATCAACGGTTTCTACGATTTTGCAGGTTACCGTAAGGATGTCCGCTATTTCGACTGTTATGGTCACATGGCTACTGGTCTTCTTGAAATGTGTGGCACAACCTTCTACTTTGATACACAAACAGGTATCCAAGCGAAAGACAAGTTTATTCGCTTCTCAGATGGCCGTATCCGTTACTTCATCCCTAATACTGGTAACATGGCTGTAAATACCTTTGTTCAAAATAAAGAAAACCAAGCTTGGTACTACCTAGATGAACATGGTTACGCTGTGACAGGAAAACGCATCATCAATGGTAAAGAATACTGCTTTGACTCAGAAGGCCGTCAAATCAAAGGTCAGATGATGCAACAAGGCAACAAGCATTACTACATTTCAGCTCAAACAGGTGAAATGGCTGTTTCACGCTTTATCTTTGAAAACAACAACTGGTATTATGCGGATGCTTTTGGTTGCCTCGTTCAAGGTGCAAAAGTAATTGATGGTAAACTCTATTACTTCAATAAAGACCACAGCCAATTAAAAGGTGGCTGGGCTGAAGGGCGTTACTATGATGCCGTTACTGGTCAAGCAGTCATTAACCAATTCATTCAAATTGCGGCTAACCAATGGGCTTACCTTAACCAAGATGGTCACAAAGTAACAGGTCTTCAAAACATTAACAATAAAGTTTACTACTTTGGTAGCAACGGTGCTCAAGTCAAAGGTAAATTGCTCACTGTCCAAGGTAAGAAATGCTACTTTGATGCCCACACTGGTGAGCAAGTGGTGAACCGCTTTGTCGAAGCTGGCCGTGGTTGCTGGTATTACTTTAACGCAGCAGGTCAAGCAGTGACTGGGAAACAGGTCATCAATGGCAAACAACTTTACTTCGACGGTTCAGGTCGTCAAGTGAAAGGACGTTATGTCTATGTTGGTGGTAAACGCCTTTTCTGCGATGCCAAAACTGGTGAATTGAGACAGCGTCGCTAA	MTIVSNSNKLFPNVTVGQSNGSNTNVTIISQGNQQNNSGYQIITGETKPSVDSNNAKSSFVRVGENQWYYYDQYGQKVKGEKVIDGKAYYFLENGLQARDSLVKGSDGYTYYYDKNGVKAINGFYDFAGYRKDVRYFDCYGHMATGLLEMCGTTFYFDTQTGIQAKDKFIRFSDGRIRYFIPNTGNMAVNTFVQNKENQAWYYLDEHGYAVTGKRIINGKEYCFDSEGRQIKGQMMQQGNKHYYISAQTGEMAVSRFIFENNNWYYADAFGCLVQGAKVIDGKLYYFNKDHSQLKGGWAEGRYYDAVTGQAVINQFIQIAANQWAYLNQDGHKVTGLQNINNKVYYFGSNGAQVKGKLLTVQGKKCYFDAHTGEQVVNRFVEAGRGCWYYFNAAGQAVTGKQVINGKQLYFDGSGRQVKGRYVYVGGKRLFCDAKTGELRQRR	MRNLTLLFLLCLSFFGTAQTVTEPKNNPAEWSKDYEPFKIVGNLYYVGTYDLASYLIVTDKGNILINTGLADSYSTIKKNIEKFGFKYKDIKILTLTQAHYDHMGAMAQIKKETGAKLYVDEKDAAELKSGGKSDYEMGKYGVTFEPVHPDFLLKNNAKIKLGNTVLTLLHHPGHTKGSCSFLFETKEGNKNYKVLIANLPSIIIDHKFSDVKKYPTIQKDYGYTFEAMKKINFDVWVASHASQFDLHKKRKEGDSYNPKLFMDKENYFKRLKDLENDYLEKVKEDSAKK	152.76	gnl|BL_ORD_ID|2028|hsp_num:0	2231			303	525	
BGC0000547.1|Salivaricin_20 # 21057 # 21146 # -1 # ID=1_20;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.333	BGC0000547.1|Salivaricin_20 	21057	21146	-	Loose	500	20.0162	Vibrio cholerae varG	31.58	3004289	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	Subclass B1 Vibrio cholerae varG beta-lactamase	AAAGCTAGAGTTCCACGGTTGGGAATCTCTAGCTTTTTTGTAGCTGAAAACTATTTTTGTCTCAGACTCTTGAATTATTTAATCACCTAG	KARVPRLGISSFFVAENYFCLRLLNYLIT	MFVSHLSFPHLIEERKMKLSTLALAPITAALLTFNASAKGHDHDNQRAIFFPGETVQDTVKVEVEPSATQSLKLGQKINNLYERQFDNSQATVQKLGKNTYWIGVNYYNATVVVNEDSVLLIDPLGDGRIDALFKGVQSITNKPITTIMYSHYHLDHLGGGNQLVDLIKKNYPKVDKIRVIASQTVADKINQHAEVGENGVKTPKVPAPNDIYDLTKPQTVQFGSMKIKMMAPKGSGHTPDNTMILIPSDRVLHFADMINPDQLPFYNFAGAEHFHGYEEDLQSLLSKPLSKQWDFINGGHGNIGSKQDVKDLLEYIADIRTEVGKQLEVAPYTPVLSDGNHFVWFKRWQDEITNNVHTALANKYGHMYGFDSGVVETHAAMILADMIDH	7.44	gnl|BL_ORD_ID|2428|hsp_num:0	2842			267	324	meropenem
